<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02100579</url>
  </required_header>
  <id_info>
    <org_study_id>STU00088239</org_study_id>
    <secondary_id>STU00088239</secondary_id>
    <nct_id>NCT02100579</nct_id>
  </id_info>
  <brief_title>Ultrasound-guided Adductor Canal Block for Total Knee Replacement</brief_title>
  <official_title>Ultrasound-guided Adductor Canal Block for Total Knee Replacement: a Randomized, Double-blind Placebo Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total knee arthroplasty is associated with intense early postoperative pain. Fast track
      recovery programs including early therapy protocols and early hospital discharge are being
      implemented at various hospitals. The postoperative analgesic pain regimen should enhance
      functional recovery in addition to providing efficient analgesia with minimal side effects.
      Adductor canal blockade is commonly used to provide postoperative analgesia for total knee
      arthroplasty (TKA) surgery. The investigators hypothesize that an ultrasound guided adductor
      canal block will lower narcotic consumption and improved overall satisfaction compared to
      ultrasound guided sham block with normal saline (placebo) for patients undergoing minimally
      invasive TKA surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators hypothesize that an ultrasound guided adductor canal block will lower
      narcotic consumption and improved overall satisfaction compared to ultrasound guided sham
      block with normal saline (placebo) for patients undergoing minimally invasive TKA surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid Consumption (mg morEq)</measure>
    <time_frame>36 hours</time_frame>
    <description>Opioid consumption (morphine equivalents)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale Pain Score</measure>
    <time_frame>Pain burden at 36hr</time_frame>
    <description>Visual Analog Scale pain score; 0 = no pain, 10 = excruciating pain) in the knee recorded every 6 hours up to 36hrs following surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospitalization</measure>
    <time_frame>0 to 192 hours</time_frame>
    <description>The average time to discharge in hours. Participants were discharged home went physical therapy criteria were met.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Complications; Arthroplasty</condition>
  <condition>Knee Injuries</condition>
  <arm_group>
    <arm_group_label>Active Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound-guided adductor canal blockade with 10 ml of 0.25% bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Ultrasound-guided sham block with 10 ml of preservative free normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>10 ml of 0.25% bupivacaine</description>
    <arm_group_label>Active Group</arm_group_label>
    <other_name>Sensorcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Preservative free normal saline</intervention_name>
    <description>10 ml of preservative free normal saline</description>
    <arm_group_label>Control Group</arm_group_label>
    <other_name>0.9% sodium chloride</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants 40 to 75 years old who are presenting for minimally invasive total knee
             arthroplasty under spinal anesthesia

        Exclusion Criteria:

          -  Patient refusal

          -  American Society of Anesthesiologists physical status classification of 4 or higher

          -  Pre-existing neuropathy in the femoral or sciatic distribution

          -  Coagulopathy

          -  Infection at the site

          -  Chronic opioid use (greater than 3 months)

          -  Pregnancy

          -  Medical conditions limiting physical therapy participation

          -  Any other contra-indication to regional anesthesia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antoun Nader, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University Feinberg School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern University Feinberg School of Medicine</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2014</study_first_submitted>
  <study_first_submitted_qc>March 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2014</study_first_posted>
  <results_first_submitted>September 14, 2016</results_first_submitted>
  <results_first_submitted_qc>September 14, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 2, 2016</results_first_posted>
  <last_update_submitted>June 14, 2017</last_update_submitted>
  <last_update_submitted_qc>June 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Antoun Nader</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Knee Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Active Group</title>
          <description>Ultrasound-guided adductor canal blockade with 10 ml of 0.25% bupivacaine
Bupivacaine: 10 ml of 0.25% bupivacaine</description>
        </group>
        <group group_id="P2">
          <title>Control Group</title>
          <description>Ultrasound-guided sham block with 10 ml of preservative free normal saline
Preservative free normal saline: 10 ml of preservative free normal saline</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Active Group</title>
          <description>Ultrasound-guided adductor canal blockade with 10 ml of 0.25% bupivacaine
Bupivacaine: 10 ml of 0.25% bupivacaine</description>
        </group>
        <group group_id="B2">
          <title>Control Group</title>
          <description>Ultrasound-guided sham block with 10 ml of preservative free normal saline
Preservative free normal saline: 10 ml of preservative free normal saline</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68" lower_limit="62" upper_limit="73"/>
                    <measurement group_id="B2" value="67" lower_limit="59" upper_limit="72"/>
                    <measurement group_id="B3" value="67" lower_limit="62" upper_limit="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Opioid Consumption (mg morEq)</title>
        <description>Opioid consumption (morphine equivalents)</description>
        <time_frame>36 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active Group</title>
            <description>Ultrasound-guided adductor canal blockade with 10 ml of 0.25% bupivacaine
Bupivacaine: 10 ml of 0.25% bupivacaine</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Ultrasound-guided sham block with 10 ml of preservative free normal saline
Preservative free normal saline: 10 ml of preservative free normal saline</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Consumption (mg morEq)</title>
          <description>Opioid consumption (morphine equivalents)</description>
          <units>Morphine Equivalents</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48" lower_limit="39" upper_limit="61"/>
                    <measurement group_id="O2" value="60" lower_limit="49" upper_limit="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Analog Scale Pain Score</title>
        <description>Visual Analog Scale pain score; 0 = no pain, 10 = excruciating pain) in the knee recorded every 6 hours up to 36hrs following surgery.</description>
        <time_frame>Pain burden at 36hr</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active Group</title>
            <description>Ultrasound-guided adductor canal blockade with 10 ml of 0.25% bupivacaine
Bupivacaine: 10 ml of 0.25% bupivacaine</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Ultrasound-guided sham block with 10 ml of preservative free normal saline
Preservative free normal saline: 10 ml of preservative free normal saline</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Scale Pain Score</title>
          <description>Visual Analog Scale pain score; 0 = no pain, 10 = excruciating pain) in the knee recorded every 6 hours up to 36hrs following surgery.</description>
          <units>scores*hours</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71" lower_limit="37" upper_limit="120"/>
                    <measurement group_id="O2" value="131" lower_limit="92" upper_limit="161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospitalization</title>
        <description>The average time to discharge in hours. Participants were discharged home went physical therapy criteria were met.</description>
        <time_frame>0 to 192 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active Group</title>
            <description>Ultrasound-guided adductor canal blockade with 10 ml of 0.25% bupivacaine
Bupivacaine: 10 ml of 0.25% bupivacaine</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Ultrasound-guided sham block with 10 ml of preservative free normal saline
Preservative free normal saline: 10 ml of preservative free normal saline</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospitalization</title>
          <description>The average time to discharge in hours. Participants were discharged home went physical therapy criteria were met.</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73" lower_limit="64" upper_limit="83"/>
                    <measurement group_id="O2" value="92" lower_limit="76" upper_limit="111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Active Group</title>
          <description>Ultrasound-guided adductor canal blockade with 10 ml of 0.25% bupivacaine
Bupivacaine: 10 ml of 0.25% bupivacaine</description>
        </group>
        <group group_id="E2">
          <title>Control Group</title>
          <description>Ultrasound-guided sham block with 10 ml of preservative free normal saline
Preservative free normal saline: 10 ml of preservative free normal saline</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Antoun Nader</name_or_title>
      <organization>Northwestern University, Feinberg School of Medicine</organization>
      <phone>312-695-3045</phone>
      <email>a-nader2@northwestern.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

